From July 1, 2023 to September 30, 2023, the company has repurchased 1,072,041 shares, representing 2.2% for $50 million. With this, the company has completed the repurchase of 10,078,173 shares, representing 21.3% for $228.89 million under the buyback announced on November 8, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.02 USD | +2.21% | +4.61% | -32.06% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.06% | 2.01B | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- AMPH Stock
- News Amphastar Pharmaceuticals, Inc.
- Tranche Update on Amphastar Pharmaceuticals, Inc.'s Equity Buyback Plan announced on November 8, 2016.